Interview with Labiotech.eu on the Sividon transaction

Sividon was a spin-off from Siemens, founded in July 2011 – and it was just sold to the American Myriad Genetics ($2.2Bn market cap) for €50M, even though the company raised only €5M over its lifetime. Philip Hemme (Co-Founder & CEO of Labiotech.eu) discussed this success story with Karlheinz Schmelig, partner of Sividon’s Lead investor Creathor Venture.

Please follow this link to read the full article in English.